drugset / Trial / NCT06976268
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A study to determine if BHV-8000 is efficacious, safe and tolerable in adults diagnosed with early Parkinson's disease. The study will consist of a 48-week double-blind treatment phase followed by a 48-week open-label phase.
Timeline
- Start
- 2025-05-28
- Primary completion
- 2027-08
- Completion
- 2028-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BHV-8000 | Unknown | 10 mg | Oral |
| Subject | BHV-8000 | Unknown | 20 mg | Oral |